Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Basbous J, Chalbos D, Hipskind R, Jariel-Encontre I, Piechaczyk M.

Mol Cell Biol. 2007 Jun;27(11):3936-50. Epub 2007 Mar 19.

2.

The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.

Ferrara P, Andermarcher E, Bossis G, Acquaviva C, Brockly F, Jariel-Encontre I, Piechaczyk M.

Oncogene. 2003 Mar 13;22(10):1461-74.

PMID:
12629509
3.

Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?

Basbous J, Jariel-Encontre I, Gomard T, Bossis G, Piechaczyk M.

Biochimie. 2008 Feb;90(2):296-305. Epub 2007 Jul 31. Review.

PMID:
17825471
5.

Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.

Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, Schmidt D, Muller S, Jariel-Encontre I, Piechaczyk M.

Mol Cell Biol. 2005 Aug;25(16):6964-79.

7.

c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.

Ito Y, Inoue D, Kido S, Matsumoto T.

Bone. 2005 Dec;37(6):842-9. Epub 2005 Sep 19.

PMID:
16172035
8.
9.

Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases.

Tsurumi C, Ishida N, Tamura T, Kakizuka A, Nishida E, Okumura E, Kishimoto T, Inagaki M, Okazaki K, Sagata N, et al.

Mol Cell Biol. 1995 Oct;15(10):5682-7.

10.

Multiple degradation pathways for Fos family proteins.

Acquaviva C, Bossis G, Ferrara P, Brockly F, Jariel-Encontre I, Piechaczyk M.

Ann N Y Acad Sci. 2002 Nov;973:426-34. Review.

PMID:
12485905
12.

A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells.

Pakay JL, Diesch J, Gilan O, Yip YY, Sayan E, Kolch W, Mariadason JM, Hannan RD, Tulchinsky E, Dhillon AS.

Oncogene. 2012 Apr 5;31(14):1817-24. doi: 10.1038/onc.2011.375. Epub 2011 Aug 29.

PMID:
21874050
13.

Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.

Talotta F, Mega T, Bossis G, Casalino L, Basbous J, Jariel-Encontre I, Piechaczyk M, Verde P.

Oncogene. 2010 Aug 19;29(33):4732-40. doi: 10.1038/onc.2010.211. Epub 2010 Jun 14.

PMID:
20543861
14.

Fos family protein degradation by the proteasome.

Gomard T, Jariel-Encontre I, Basbous J, Bossis G, Moquet-Torcy G, Piechaczyk M.

Biochem Soc Trans. 2008 Oct;36(Pt 5):858-63. doi: 10.1042/BST0360858. Erratum in: Biochem Soc Trans. 2013 Dec;41(6):1773. Mocquet-Torcy, Gabriel [corrected to Moquet-Torcy, Gabriel].

PMID:
18793151
15.

Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1.

Julien M, Khoshniat S, Lacreusette A, Gatius M, Bozec A, Wagner EF, Wittrant Y, Masson M, Weiss P, Beck L, Magne D, Guicheux J.

J Bone Miner Res. 2009 Nov;24(11):1856-68. doi: 10.1359/jbmr.090508.

16.
17.

Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope.

González JM, Navarro-Puche A, Casar B, Crespo P, Andrés V.

J Cell Biol. 2008 Nov 17;183(4):653-66. doi: 10.1083/jcb.200805049.

18.

Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway.

Gilbert SJ, Blain EJ, Duance VC, Mason DJ.

Arthritis Rheum. 2008 Jan;58(1):209-20. doi: 10.1002/art.23172.

19.

Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent.

Beck GR Jr, Knecht N.

J Biol Chem. 2003 Oct 24;278(43):41921-9. Epub 2003 Aug 13.

20.

Molecular interpretation of ERK signal duration by immediate early gene products.

Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J.

Nat Cell Biol. 2002 Aug;4(8):556-64.

PMID:
12134156

Supplemental Content

Support Center